Evidence map›Paper›PMID 33671524›Full record

ReviewInternational journal of molecular sciences2021

The Endothelial Glycocalyx as a Target of Ischemia and Reperfusion Injury in Kidney Transplantation-Where Have We Gone So Far?

Anila Duni, Vassilios Liakopoulos, Vasileios Koutlas, Charalampos Pappas, Michalis Mitsis, Evangelia Dounousi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. The Role of IGL-2 Preservation Solution on Rat Livers during SCS and HOPE.International journal of molecular sciences · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Anila DuniDepartment of Nephrology, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45110 Ioannina, Greece.
Vassilios LiakopoulosDivision of Nephrology and Hypertension, 1st Department of Internal Medicine, Medical School Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.ORCID 0000-0002-7564-2724
Vasileios KoutlasKidney Transplant Unit, Department of Surgery, University Hospital of Ioannina, 45500 Ioannina, Greece.
Charalampos PappasDepartment of Nephrology, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45110 Ioannina, Greece.
Michalis MitsisKidney Transplant Unit, Department of Surgery, University Hospital of Ioannina, 45500 Ioannina, Greece.
Evangelia DounousiDepartment of Nephrology, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0002-1172-1829
University of Ioannina · GRUniversity Hospital of Ioannina · GRAristotle University of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The damage of the endothelial glycocalyx as a consequence of ischemia and/or reperfusion injury (IRI) following kidney transplantation has come at the spotlight of research due to potential associations with delayed graft function, acute rejection as well as long-term allograft dysfunction. The disintegration of the endothelial glycocalyx induced by IRI is the crucial event which exposes the denuded endothelial cells to further inflammatory and oxidative damage. The aim of our review is to present the currently available data regarding complex links between shedding of the glycocalyx components, like syndecan-1, hyaluronan, heparan sulphate, and CD44 with the activation of intricate immune system responses, including toll-like receptors, cytokines and pro-inflammatory transcription factors. Evidence on modes of protection of the endothelial glycocalyx and subsequently maintenance of endothelial permeability as well as novel nephroprotective molecules such as sphingosine-1 phosphate (S1P), are also depicted. Although advances in technology are making the visualization and the analysis of the endothelial glycocalyx possible, currently available evidence is mostly experimental. Ongoing progress in understanding the complex impact of IRI on the endothelial glycocalyx, opens up a new era of research in the field of organ transplantation and clinical studies are of utmost importance for the future.

Indexed as

EndotheliumGlycocalyxHeparan SulfateHumansHyaluronic AcidIschemiaKidneyKidney TransplantationLysophospholipidsReperfusion InjurySphingosineHeparan SulfateHyaluronic AcidLysophospholipidsSphingosinesphingosine 1-phosphateendothelial glycocalyximmune responsesinflammationischemia and/or reperfusion injurykidney transplantation

Identifiers

PMID33671524
PMCPMC7926299
OpenAlexW3131291070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.